Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (41)

    MIT engineers create nanoparticles for delivering personalized cancer vaccines

    MIT engineers create nanoparticles for delivering personalized cancer vaccines

    A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create a
    October 30, 2026
    The long history of vaccine hesitancy

    The long history of vaccine hesitancy

    Debates about vaccines are a recurring feature of contemporary politics. It turns out they actually date back more than 200 years, since the development of the first smallpox vaccine. MIT Professor Thomas Levenson, one of the country’s leading science writers, explores this important history in a new book about the contours of anti-vaccination thought. Levenson identifies different types of argume
    June 12, 2026
    A new vaccine adjuvant could make it easier to eradicate polio

    A new vaccine adjuvant could make it easier to eradicate polio

    In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn’t block transmission of the polio virus as well as the oral polio vaccine does.Poliovirus is usually transmitted through contaminated food or water, so the GI tract is where the body is first exposed. Because the oral vaccine induces a mucosal
    June 3, 2026
    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    New vaccine platform promotes rare protective B cells

    New vaccine platform promotes rare protective B cells

    A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and influenza. Of particular interest are antibodies that are “broadly neutralizing,” meaning they can in principle eliminate multiple strains of a virus such as HIV, which mutates rapidly to evade the human immune system.Researchers at MIT and the Scripps Resear
    February 5, 2026
    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.“One of the cha
    November 7, 2025
    MIT study finds targets for a new tuberculosis vaccine

    MIT study finds targets for a new tuberculosis vaccine

    A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.In the new study, a team of MIT biological engineers was able to identify a handful of immunogenic peptides, out of more than 4,000 bacterial proteins, that appear to stimulate a strong response from a type of T cells respons
    November 5, 2025
    MIT researchers develop AI tool to improve flu vaccine strain selection

    MIT researchers develop AI tool to improve flu vaccine strain selection

    Every year, global health experts are faced with a high-stakes decision: Which influenza strains should go into the next seasonal vaccine? The choice must be made months in advance, long before flu season even begins, and it can often feel like a race against the clock. If the selected strains match those that circulate, the vaccine will likely be highly effective. But if the prediction is off, pr
    August 28, 2025
    Study in India shows several tactics together boost vaccination against deadly diseases

    Study in India shows several tactics together boost vaccination against deadly diseases

    Around the world, low immunizations rates for children are a persistent problem. Now, an experiment conducted in India shows that an inexpensive combination of methods, including text reminders and small financial incentives, has a major impact on immunization.Led by MIT economists, the research finds that a trifecta of incentives, text messages, and information provided by local residents creates
    May 19, 2025
    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Around the world, 20 percent of children are not fully immunized, leading to 1.5 million child deaths each year from diseases that are preventable by vaccination. About half of those underimmunized children received at least one vaccine dose but did not complete the vaccination series, while the rest received no vaccines at all.To make it easier for children to receive all of their vaccines, MIT r
    May 15, 2025
    Biologists identify targets for new pancreatic cancer treatments

    Biologists identify targets for new pancreatic cancer treatments

    Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic tumors.Known as cryptic peptides, these molecules are produced from sequences in the genome that were not thought to encode proteins. Such peptides can also be found in some h
    May 8, 2025
    Is this the new playbook for curing rare childhood diseases?

    Is this the new playbook for curing rare childhood diseases?

    “There is no treatment available for your son. We can’t do anything to help him.”When Fernando Goldsztein MBA ’03 heard those words, something inside him snapped.“I refused to accept what the doctors were saying. I transformed my fear into my greatest strength and started fighting.”Goldsztein’s 12-year-old son Frederico was diagnosed with relapsing medulloblastoma, a life-threatening pediatric bra
    January 24, 2025
    A new approach to modeling complex biological systems

    A new approach to modeling complex biological systems

    Over the past two decades, new technologies have helped scientists generate a vast amount of biological data. Large-scale experiments in genomics, transcriptomics, proteomics, and cytometry can produce enormous quantities of data from a given cellular or multicellular system.However, making sense of this information is not always easy. This is especially true when trying to analyze complex systems
    November 5, 2024
    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K. Shalek, and Darrell J. Irvine, in conjunction with a group at Georgia Tech led by M.G. Finn, has revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears today in ACS Nano, produces exactly the type of anti-tumor immunity need
    September 16, 2024
    Hitchhiking cancer vaccine makes progress in the clinic

    Hitchhiking cancer vaccine makes progress in the clinic

    Therapeutic cancer vaccines are an appealing strategy for treating malignancies. In theory, when a patient is injected with peptide antigens — protein fragments from mutant proteins only expressed by tumor cells — T cells learn to recognize and attack cancer cells expressing the corresponding protein. By teaching the patient’s own immune system to attack cancer cells, these vaccines ideally would
    February 15, 2024
    MIT-led team receives funding to pursue new treatments for metabolic disease

    MIT-led team receives funding to pursue new treatments for metabolic disease

    A team of MIT researchers will lead a $65.67 million effort, awarded by the U.S. Advanced Research Projects Agency for Health (ARPA-H), to develop ingestible devices that may one day be used to treat diabetes, obesity, and other conditions through oral delivery of mRNA. Such devices could potentially be deployed for needle-free delivery of mRNA vaccines as well.The five-year project also aims to d
    February 5, 2024
    MIT’s tiny technologies go to Washington

    MIT’s tiny technologies go to Washington

    On Nov. 7, a team from the Marble Center for Cancer Nanomedicine at MIT showed a Washington audience several examples of how nanotechnologies developed at the Institute can transform the detection and treatment of cancer and other diseases.The team was one of 40 innovative groups featured at “American Possibilities: A White House Demo Day.” Technology on view spanned energy, artificial intelligenc
    December 18, 2023
    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: a nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles contain saponin, a compound derived from the bark of the Chilean soapbark tree, along with a molecule called MPLA, each of which helps to activate the immune system. The adj
    December 12, 2023
    MIT engineers design more powerful RNA vaccines

    MIT engineers design more powerful RNA vaccines

    RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.Adjuvants are molecules commonly used to increase the immu
    September 7, 2023
    A snapshot of cancer vaccine development

    A snapshot of cancer vaccine development

    The road to effective cancer vaccines has been long and difficult.  Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleucel-T was used to treat prostate cancer in 2010. While the FDA-approved prostate cancer vaccine generated much excitement, its success has proven diffi
    August 15, 2023
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.